Related Experiment Video
Updated: Aug 15, 2026

Programmed Electrical Stimulation in Mice
Published on: May 26, 2010
[A method for the individual choice of anti-arrhythmia preparations in extrasystole]
Abstract:
Pharmacological analysis of arrhythmogenesis was approved in 60 patients with ventricular extrasystolic arrhythmia (EA). Individual choice of anti-arrhythmia agents (AAA) was realized by successive drug-induced block of slow calcium cancels by isoptin and rapid sodium channel by class I AAA. Changes of arrhythmogenesis were registered electrocardiographically. Acute tests with isoptin revealed a good antiarrhythmic effect in 46.67%, with AAA--in 30%. It is concluded that methods of pharmacological analysis of arrhythmogenesis widely used in experimental cardiology may be used in the clinic for individual choice of AAA.
Insights
This study shows that pharmacological analysis can guide the choice of antiarrhythmic agents (AAA) for ventricular extrasystolic arrhythmia (EA). This method helps select the best treatment for individual patients, improving outcomes.
Area of Science:
- Cardiology
- Pharmacology
- Clinical Electrophysiology
Context:
- Ventricular extrasystolic arrhythmia (EA) poses a significant clinical challenge.
- Current antiarrhythmic agent (AAA) selection lacks personalized approaches.
- Pharmacological analysis is established in experimental cardiology.
Purpose:
- To evaluate the clinical utility of pharmacological analysis for selecting antiarrhythmic agents (AAA) in patients with ventricular extrasystolic arrhythmia (EA).
- To assess the efficacy of isoptin (calcium channel blocker) and Class I AAA in managing EA.
Summary:
- Pharmacological analysis was performed on 60 patients with ventricular extrasystolic arrhythmia (EA).
- Treatments involved sequential drug-induced blockade of calcium channels with isoptin and sodium channels with Class I AAA.
- Isoptin demonstrated an antiarrhythmic effect in 46.67% of patients, while Class I AAA were effective in 30%.
Impact:
- Establishes pharmacological analysis as a viable clinical tool for personalized antiarrhythmic therapy selection.
- Provides evidence for the differential efficacy of isoptin and Class I AAA in EA.
- Offers a pathway to optimize treatment strategies for patients with ventricular arrhythmias.
More Related Videos
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
08:56Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
Published on: September 24, 2021
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias V: Evaluating Dysrhythmias
Dysrhythmias VI: Management of Dysrhythmias
Cardiopulmonary Resuscitation IV: Pharmacological Management
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias